Click the image to the left and log in to get your exclusive reader perks.
Search / 148 results found Showing: 1-10 of 148
MONDAY, Jan. 24, 2022 (HealthDay News) -- For health care workers who received a priming dose of the Ad26.COV2.S vaccine, Ad26.COV2.S and mRNA boosters are immunogenic, with the strongest responses after boosting with an mRNA-based vaccine, according to a study published online Jan. 19 in the New England Journal of Medicine.
FRIDAY, Jan. 21, 2022 (HealthDay News) -- Booster shots are keeping the Omicron variant from landing millions of Americans in hospitals, emergency rooms and urgent care clinics across the country, three new government studies show.
FRIDAY, Jan. 21, 2022 (HealthDay News) -- One less excuse to avoid that COVID vaccine: The shots don't affect fertility in either men or women, new research shows, but coronavirus infection could cause short-term fertility problems in men.
FRIDAY, Jan. 21, 2022 (HealthDay News) -- Vaccine effectiveness against symptomatic COVID-19 decreases by 20 weeks after the second dose of BNT162b2 or CHAdOx1-S, but limited waning is seen against COVID-19-related hospitalization and death, according to a study published online Jan. 12 in the New England Journal of Medicine.
FRIDAY, Jan. 21, 2022 (HealthDay News) -- The risk of hospitalization for COVID-19 among older Americans is far higher for those who are unvaccinated than for those who are fully vaccinated and have had a booster shot, new government data shows.
FRIDAY, Jan. 21, 2022 (HealthDay News) -- Some arthritis drugs may reduce the effectiveness of COVID vaccines, according to the Arthritis Foundation, which also offers advice on booster shots.
THURSDAY, Jan. 20, 2022 (HealthDay News) -- Recommendations have been updated for use of the recombinant zoster vaccine (RZV) for prevention of herpes zoster and related complications among immunocompromised adults aged 19 years and older; the recommendations are available in the Jan. 21 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
THURSDAY, Jan. 20, 2022 (HealthDay News) -- A fourth dose of an mRNA-based anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine may increase antispike immunoglobulin (Ig)G titers in kidney transplant recipients, according to a research letter published online Jan. 11 in the Annals of Internal Medicine.
WEDNESDAY, Jan. 19, 2022 (HealthDay News) -- If COVID-19 vaccines and medicines are shared equally worldwide, the pandemic could ease this year, a top World Health Organization official said Tuesday.
WEDNESDAY, Jan. 19, 2022 (HealthDay News) -- Two doses of the BNT162b2 vaccine are highly effective against COVID-19-related hospitalization and critical disease in adolescents aged 12 to 18 years, according to a study published online Jan. 12 in the New England Journal of Medicine.